Evidence map›Paper›PMID 30616488›Full record

ArticleSLAS discovery : advancing life sciences R & D2019

Unbiased Phenotype Detection Using Negative Controls.

Antje Janosch, Carolin Kaffka, Marc Bickle

Abstract read
In one paragraph

Article in SLAS discovery : advancing life sciences R & D, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Academic Pill: How Academia Contributes to Curing Diseases.SLAS discovery : advancing life sciences R & D · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Antje Janosch1 Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
Carolin Kaffka2 Fraunhofer-Institut für Verkehrs- und Infrastruktursysteme, Dresden, Germany.
Marc Bickle1 Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.ORCID 0000-0002-8918-1869

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenotypic screens using automated microscopy allow comprehensive measurement of the effects of compounds on cells due to the number of markers that can be scored and the richness of the parameters that can be extracted. The high dimensionality of the data is both a rich source of information and a source of noise that might hide information. Many methods have been proposed to deal with this complex data in order to reduce the complexity and identify interesting phenotypes. Nevertheless, the majority of laboratories still only use one or two parameters in their analysis, likely due to the computational challenges of carrying out a more sophisticated analysis. Here, we present a novel method that allows discovering new, previously unknown phenotypes based on negative controls only. The method is compared with L1-norm regularization, a standard method to obtain a sparse matrix. The analytical pipeline is implemented in the open-source software KNIME, allowing the implementation of the method in many laboratories, even ones without advanced computing knowledge.

Indexed as

PharmacologyPhenotypeAutomationMicroscopySoftwarefingerprintinghigh-content screeningmultiparametric analysis

Identifiers

PMID30616488
PMCPMC6484531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.